Introduction Lung cancer is the leading cause of cancer mortality worldwide; lung
adenocarcinoma (LUAD) corresponds to about 40% of lung cancers. LUAD is a genetically …

Invasive mucinous adenocarcinoma of the lung (IMA) is a unique and rare subtype of lung
adenocarcinoma with poorly defined prognostic factors and highly controversial studies …

Background According to the latest the World Health Organization (WHO) classification in
2015, invasive mucinous adenocarcinoma (IMA) is defined as a new pathological subtype of …

Background Invasive mucinous adenocarcinoma (IMA) of the lung is a rare and distinct
subtype of adenocarcinoma. At present, people have no idea whether IMA patients can …

目的肺黏液腺癌是一种罕见的肺癌亚型, 存在独特的分子生物学特征, 并影响治疗方案的选择.
本研究拟通过建立浸润性黏液腺癌的机器学习模型来提高治疗前黏液腺癌诊断的准确性 …

Background The prognosis of invasive mucinous adenocarcinoma (IMA) remains
controversial and should be clarified by comparison with the International Association for the …

Histologic grading of tumors is associated with prognosis in many organs. In the lung, the
most recent grading system proposed by International association for the Study of Lung …

Background At present, there is a lack of studies in invasive mucinous adenocarcinoma
(IMA) that combine clinicopathological and imaging features to stratify risk and select optimal …

Background The prognostic-related factors of lung invasive mucinous adenocarcinoma
(IMA) are unclear because of its rarity. Various inflammation-based biomarkers were …

Objective: This study aimed to develop and validate predictive models using clinical
parameters, radiomic features, and a combination of both for invasive mucinous …